Article
Use of intravitreal steroid injections needs to be fully explored for safety as well as efficacy
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Q&A: Matthew Starr, MD, shares insights into RHONE-X trial
FDA grants Breakthrough Therapy Designation for Tinlarebant